Market Overview

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

87.26 +3.09 (3.67%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2019
After-Hours
EPS:
REV:
-1.82
21.033M



Q3 2019
Pre-Market
EPS:
REV:
-1.56
2.069M



Q2 2019
Pre-Market
EPS:
REV:
-1.61
29.907M



Q1 2019
After-Hours
EPS:
REV:
-1.22
21.899M



Q4 2018
After-Hours
EPS:
REV:
-1.20
37.924M
-2.28
15.19M
-1.82
21.033M
-20.18%
38.47%
Q3 2018
Pre-Market
EPS:
REV:
-1.06
17.096M
-2.01
18.23M
-1.56
2.069M
-22.39%
-88.65%
Q2 2018
Pre-Market
EPS:
REV:
-1.34
15.932M
-1.77
17.97M
-1.61
29.907M
-9.04%
66.43%
Q1 2018
After-Hours
EPS:
REV:
-1.25
18.96M
-1.50
30.15M
-1.22
21.899M
-18.67%
-27.37%
Q4 2017
Pre-Market
EPS:
REV:
-1.32
17.454M
-1.41
21.8M
-1.20
37.924M
-14.89%
73.96%
Q3 2017
After-Hours
EPS:
REV:
-1.21
13.651M
-1.27
24.65M
-1.06
17.096M
-16.54%
-30.65%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!